Edition:
United States

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

3,435JPY
16 Jan 2017
Change (% chg)

¥-15 (-0.43%)
Prev Close
¥3,450
Open
¥3,435
Day's High
¥3,460
Day's Low
¥3,410
Volume
801,600
Avg. Vol
1,161,984
52-wk High
¥4,000
52-wk Low
¥3,010

4519.T

Chart for 4519.T

About

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as... (more)

Overall

Beta: 0.64
Market Cap(Mil.): ¥1,930,916.00
Shares Outstanding(Mil.): 559.69
Dividend: 26.00
Yield (%): 1.51

Financials

  4519.T Industry Sector
P/E (TTM): 33.36 30.00 30.92
EPS (TTM): 103.40 -- --
ROI: 8.83 15.39 14.82
ROE: 9.09 16.57 16.24

Swiss stocks - Factors to watch on Jan 16

ZURICH, Jan 16 The Swiss blue-chip SMI was seen opening 0.2 percent easier at 8,436 points on Monday, according to premarket indications by bank Julius Baer .

2:05am EST

BRIEF-Chugai, Berlin-Chemie Menarini set license agreement for PA799

* Roche's chugai and Berlin-Chemie Menarini Group announce global license agreement for an anti-cancer agent PA799 Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

Nov 28 2016

BRIEF-Chugai and Galderma announce global license agreement for Nemolizumab

* Chugai will continue to be responsible for product manufacturing and supply of Nemolizumab.

Jul 20 2016

Earnings vs. Estimates